Atlas Trials

Phase 2 Study of NGM282 in Patients With Type 2 Diabetes

Clinical trial NCT01943045 · COMPLETED

Trial details

NCT number
NCT01943045
Sponsor
NGM Biopharmaceuticals, Inc
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2013-09-01
Primary completion
2014-09-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.